Bajaj Healthcare Ltd has executed a Deed of Assignment to sell its non-operational business unit in the Dahej Industrial Area, Gujarat, to Spa Vet Private Limited and Indosol Pure Technologies Private Limited for approximately Rs 14.67 crore. The asset was inactive during the last fiscal year and contributed nothing to revenue, marking this as a strategic monetization of idle capacity.
Bajaj Healthcare Divests Non-Core Gujarat Asset for Rs 14.67 Crore
Total consideration for the Dahej unit sale stands at Rs 14.67 crore. The asset was inactive throughout the previous financial year.
Reader Takeaway: Company successfully monetizes idle non-core assets while ensuring no impact on existing revenue streams.
What just happened
Bajaj Healthcare Ltd has officially executed a Deed of Assignment for the sale of its business undertaking located at Plot No. D-2/CH/42 & D-2/CH/43 in the Dahej Industrial Area, Bharuch, Gujarat. The agreement was signed on October 12, 2026, with Spa Vet Private Limited and Indosol Pure Technologies Private Limited as the buyers. The total consideration for the transfer is approximately Rs 14.67 crore.
Why this matters
Investors should note that this unit was not operational during the previous financial year. By selling this idle capacity, Bajaj Healthcare is effectively cleaning up its balance sheet and monetizing a non-core asset that provided zero contribution to its current revenue or net worth. The transaction aligns with the company's previously stated strategy of shedding non-performing capacity.
Corporate Compliance
Bajaj Healthcare has confirmed that this transaction is not a Related Party Transaction, as the buyers have no connection to the company’s promoter or promoter group. Necessary shareholder approval for this divestment was secured via a Postal Ballot process back on August 5, 2023. Additionally, the company is maintaining its trading window closure for designated persons in compliance with its internal insider trading policy.
What to track next
Shareholders should monitor the company’s upcoming quarterly filings to see how these proceeds are deployed, specifically if the funds are used for debt reduction or reinvestment into core manufacturing operations.
